These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 15338120)

  • 1. Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil.
    Hazzan M; Provot F; Glowacki F; Copin MC; Roumilhac D; Labalette M; Pruvot FR; Noel C
    Transpl Int; 2004 Oct; 17(9):525-30. PubMed ID: 15338120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcome of pediatric kidney transplantations in the Netherlands -- effect of the introduction of mycophenolate mofetil?
    Cransberg K; Marlies Cornelissen EA; Davin JC; Van Hoeck KJ; Lilien MR; Stijnen T; Nauta J
    Pediatr Transplant; 2005 Feb; 9(1):104-11. PubMed ID: 15667622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
    Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A
    Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised open clinical trial of conversion from mycophenolate mofetil to azathioprine in cadaveric renal transplantation.
    Nowacka-Cieciura E; Kamiñska B; Cieciura T; Gradowska L; Pazik J; Lao M; Rowiñski W; Paczek L
    Transpl Int; 2000; 13 Suppl 1():S68-72. PubMed ID: 11111965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective use of mycophenolate mofetil in renal transplant patients in Indian scenario.
    Srivastava A; Singh V; Kumar A; Sharma RK; Gupta A
    Transplant Proc; 2004 Sep; 36(7):2060-4. PubMed ID: 15518746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
    Tsai MK; Hu RH; Lee CJ; Lee PH
    J Formos Med Assoc; 2002 Sep; 101(9):616-21. PubMed ID: 12645188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.
    Song Y; Xue W; Tian P; Ding X; Pan X; Yan H; Hou J; Feng X; Xiang H; Tian X; Qin G; Fan X
    Eur J Clin Pharmacol; 2011 Jun; 67(6):553-62. PubMed ID: 21279337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
    Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil in pediatric renal transplantation.
    Otukesh H; Sharifian M; Basiri A; Simfroosh N; Hoseini R; Sedigh N; Golnari P; Rezai M; Fereshtenejad M
    Transplant Proc; 2005 Sep; 37(7):3012-5. PubMed ID: 16213289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study.
    Imamović G; Zerem E; Osmanović E
    Eur J Intern Med; 2010 Dec; 21(6):524-9. PubMed ID: 21111938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of sensitization.
    Katznelson S; Bhaduri S; Cecka JM
    Clin Transpl; 1997; ():285-96. PubMed ID: 9919412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of mycophenolate mofetil in patients with a transplanted kidney and cyclosporin nephrotoxicity].
    Hrvacević R; Ignjatović Lj; Vavić N; Dimitrijević J; Drasković-Pavlović B; Dujić A; Elaković D; Kronja G; Marić M
    Vojnosanit Pregl; 2001; 58(2):157-60. PubMed ID: 11475669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
    Kovac D; Kotnik V; Kandus A
    Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine.
    Lee CM; Markezich AJ; Scandling JD; Dafoe DC; Alfrey EJ
    J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
    Attallah N; Goggins M; Nori U; Abouljoud M; Zasuwa G; Venkat KK; Parasuraman R
    Transplant Proc; 2005 Jun; 37(5):2060-2. PubMed ID: 15964338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.